Go Pro

Kyle Mikson Analyst Performance

Managing Director, Senior Research Analyst at Canaccord Genuity Group

Kyle Mikson is a stock analyst at Canaccord Genuity Group focused in the medical sector, covering 21 publicly traded companies. Over the past year, Kyle Mikson has issued 64 stock ratings, including strong buy, buy, and hold recommendations. While full access to Kyle Mikson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kyle Mikson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
98 Last 4 Years
Buy Recommendations
69.23% 63 Buy Ratings
Companies Covered
21 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy1.1%1 ratings
Buy68.1%62 ratings
Hold30.8%28 ratings
Sell0.0%0 ratings

Out of 91 total stock ratings issued by Kyle Mikson at Canaccord Genuity Group, the majority (68.1%) have been Buy recommendations, followed by 30.8% Hold and 1.1% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
21 companies

Kyle Mikson, an analyst at Canaccord Genuity Group, currently covers 21 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
19 companies
90.5%
Services
1 company
4.8%
Computer and Technology
1 company
4.8%

Kyle Mikson of Canaccord Genuity Group specializes in stock coverage within the Medical sector, with additional focus on Services and Computer and Technology companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
8 companies
38.1%
MEDICAL SERVICES
3 companies
14.3%
MED INSTRUMENTS
3 companies
14.3%
MED PRODUCTS
2 companies
9.5%
MEDICAL INFO SYS
2 companies
9.5%
SERVICES – HEALTH
1 company
4.8%
ELEC COMP - SEMIC
1 company
4.8%
SURGICAL & MEDICAL INSTRUMENTS
1 company
4.8%

Kyle Mikson's Ratings History at Canaccord Genuity Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Biodesix, Inc. stock logo
BDSX
Biodesix
6/18/2026Boost Price Target$16.09$27.00Buy
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
6/15/2026Initiated Coverage$76.17$90.00Buy
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
6/15/2026Initiated Coverage$80.79$90.00Buy
Veracyte, Inc. stock logo
VCYT
Veracyte
5/6/2026Boost Price Target$37.62$42.00Hold
GeneDx Holdings Corp. stock logo
WGS
GeneDx
5/5/2026Set Price Target$67.93$75.00Buy
Biodesix, Inc. stock logo
BDSX
Biodesix
5/5/2026Boost Price Target$14.78$22.00Buy
Seer, Inc. stock logo
SEER
Seer
5/4/2026Initiated Coverage$2.03$4.00Buy
Seer, Inc. stock logo
SEER
Seer
5/4/2026Upgrade$1.86$4.00Strong-Buy
Illumina, Inc. stock logo
ILMN
Illumina
5/1/2026Lower Price Target$126.74$140.00Hold
Exagen Inc. stock logo
XGN
Exagen
4/20/2026Lower Price Target$2.96$8.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
4/20/2026Set Price Target$68.51$100.00Buy
Repligen Corporation stock logo
RGEN
Repligen
4/20/2026Lower Price Target$132.53$145.00Hold
Quanterix Corporation stock logo
QTRX
Quanterix
4/20/2026Lower Price Target$3.43$4.00Hold
Castle Biosciences, Inc. stock logo
CSTL
Castle Biosciences
4/20/2026Lower Price Target$25.21$40.00Buy
Veracyte, Inc. stock logo
VCYT
Veracyte
4/20/2026Lower Price Target$33.40$40.00Hold
10x Genomics stock logo
TXG
10x Genomics
4/20/2026Boost Price Target$25.25$32.00Buy
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
3/13/2026Lower Price Target$18.10$22.00Hold
Exagen Inc. stock logo
XGN
Exagen
3/11/2026Lower Price Target$3.08$10.00Buy
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
3/4/2026Lower Price Target$0.93$1.00Hold
GRAIL, Inc. stock logo
GRAL
GRAIL
2/20/2026Lower Price Target$101.53$80.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
2/20/2026Boost Price Target$106.38$135.00Buy
Biodesix, Inc. stock logo
BDSX
Biodesix
2/17/2026Reiterated Rating$11.11$20.00Buy
10x Genomics stock logo
TXG
10x Genomics
2/13/2026Set Price Target$17.51$22.00
Illumina, Inc. stock logo
ILMN
Illumina
1/26/2026Boost Price Target$150.28$150.00Hold
Natera, Inc. stock logo
NTRA
Natera
1/12/2026Reiterated Rating$234.31Buy
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
12/22/2025Boost Price Target$27.94$30.00Hold
10x Genomics stock logo
TXG
10x Genomics
12/22/2025Boost Price Target$16.05$20.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
12/22/2025Lower Price Target$64.46$80.00Buy
Quanterix Corporation stock logo
QTRX
Quanterix
12/22/2025Boost Price Target$6.59$8.00Hold
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
12/22/2025Lower Price Target$1.27$1.50Hold
Natera, Inc. stock logo
NTRA
Natera
12/22/2025Boost Price Target$231.96$285.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
12/22/2025Boost Price Target$134.78$130.00Hold
Guardant Health, Inc. stock logo
GH
Guardant Health
12/22/2025Boost Price Target$99.74$125.00Buy
Castle Biosciences, Inc. stock logo
CSTL
Castle Biosciences
12/22/2025Boost Price Target$39.44$50.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
12/22/2025Boost Price Target$140.44$170.00Buy
Natera, Inc. stock logo
NTRA
Natera
12/8/2025Reiterated Rating$241.17$250.00Buy
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
12/2/2025Initiated Coverage$28.86$28.00Hold
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
11/25/2025Downgrade$101.01$105.00Hold
GRAIL, Inc. stock logo
GRAL
GRAIL
11/17/2025Boost Price Target$79.63$105.00Buy
Natera, Inc. stock logo
NTRA
Natera
11/7/2025Boost Price Target$199.57$250.00Buy
SpaceX IPO hides a much bigger story (Ad)

The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. Elon believes what Michael Robinson calls 'Project Unlimited' could unlock $100 trillion in potential growth. One little-known company sits at the center of it all, and most investors have no idea it exists. Position yourself before this company potentially hits the front page.tc pixel

Click here to see the details before the crowd catches on
10x Genomics stock logo
TXG
10x Genomics
11/7/2025Boost Price Target$15.25$19.00Buy
Veracyte, Inc. stock logo
VCYT
Veracyte
11/5/2025Boost Price Target$36.12$43.00Hold
Tempus AI, Inc. stock logo
TEM
Tempus AI
11/5/2025Lower Price Target$84.49$95.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
10/31/2025Boost Price Target$99.01$112.00Hold
Guardant Health, Inc. stock logo
GH
Guardant Health
10/30/2025Set Price Target$72.27$100.00
Guardant Health, Inc. stock logo
GH
Guardant Health
10/30/2025Boost Price Target$72.27$100.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
10/29/2025Set Price Target$140.19$160.00Buy
Repligen Corporation stock logo
RGEN
Repligen
10/29/2025Boost Price Target$152.85$165.00Hold
Exagen Inc. stock logo
XGN
Exagen
10/27/2025Boost Price Target$11.96$15.00Buy
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
10/27/2025Boost Price Target$2.29$2.00Hold
GRAIL, Inc. stock logo
GRAL
GRAIL
10/22/2025Boost Price Target$81.33$85.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
10/20/2025Set Price Target$120.94$155.00Buy
Veracyte, Inc. stock logo
VCYT
Veracyte
10/20/2025Initiated Coverage$35.83$40.00Hold
Tempus AI, Inc. stock logo
TEM
Tempus AI
10/20/2025Initiated Coverage$87.78$110.00Buy
Natera, Inc. stock logo
NTRA
Natera
10/14/2025Reiterated Rating$172.81$200.00Buy
GRAIL, Inc. stock logo
GRAL
GRAIL
10/3/2025Boost Price Target$72.37$75.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
9/26/2025Boost Price Target$60.18$75.00Buy
Biodesix, Inc. stock logo
BDSX
Biodesix
9/19/2025Set Price Target$6.77$20.00Buy
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
9/9/2025Reiterated Rating$1.08$1.00Hold
Castle Biosciences, Inc. stock logo
CSTL
Castle Biosciences
9/9/2025Reiterated Rating$24.05$37.00Buy
10x Genomics stock logo
TXG
10x Genomics
8/11/2025Set Price Target$12.41$16.00
Quanterix Corporation stock logo
QTRX
Quanterix
8/11/2025Reiterated Rating$4.75$5.00Hold
Illumina, Inc. stock logo
ILMN
Illumina
8/1/2025Boost Price Target$96.17$105.00Hold
Exagen Inc. stock logo
XGN
Exagen
7/30/2025Boost Price Target$8.45$11.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
6/11/2025Boost Price Target$87.98$99.00Hold
Biodesix, Inc. stock logo
BDSX
Biodesix
5/14/2025Lower Price Target$4.40$30.00Buy
Exagen Inc. stock logo
XGN
Exagen
5/13/2025Boost Price Target$5.48$8.00Buy
Quanterix Corporation stock logo
QTRX
Quanterix
5/13/2025Lower Price Target$4.75$12.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
5/12/2025Lower Price Target$75.76$87.00Hold
10x Genomics stock logo
TXG
10x Genomics
5/12/2025Lower Price Target$9.44$15.00Buy
Castle Biosciences, Inc. stock logo
CSTL
Castle Biosciences
5/6/2025Lower Price Target$18.75$37.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
5/1/2025Boost Price Target$48.89$65.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
4/29/2025Lower Price Target$77.22$92.00Hold
Biodesix, Inc. stock logo
BDSX
Biodesix
4/29/2025Lower Price Target$11.40$50.00Buy
GRAIL, Inc. stock logo
GRAL
GRAIL
4/21/2025Initiated Coverage$27.00$32.00Buy
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
4/10/2025Reiterated Rating$1.38$3.00Buy
Quanterix Corporation stock logo
QTRX
Quanterix
3/18/2025Lower Price Target$7.28$15.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
3/11/2025Lower Price Target$85.97$115.00Hold
Natera, Inc. stock logo
NTRA
Natera
2/26/2025Reiterated Rating$161.43$180.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
2/24/2025Boost Price Target$42.87$60.00Buy
10x Genomics stock logo
TXG
10x Genomics
2/13/2025Lower Price Target$11.94$18.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
2/7/2025Lower Price Target$112.34$135.00Hold